Search research articles
Contact Us
Filters
Showing results (11-20 of 73) with videos related to
Page
of 8
Sort By:
Neurology
|
February 25, 2011
Is brain the new bone marrow? Stem cells, cancer, and cognition: a working hypothesis
Nimish A Mohile, Christina M Zoccoli, Michael Glantz
Neurology
|
August 12, 2021
VEGF and Immune Checkpoint Inhibition for Prevention of Brain Metastases: Systematic Review and Meta-analysis
Alireza Mansouri, Varun Padmanaban, Dawit Aregawi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2005
Regarding "abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial"
Marc C Chamberlain, Lawrence D Recht, Michael Glantz
Nature Clinical Practice. Oncology
|
October 22, 2008
New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer
Michelle E Melisko, Michael Glantz, Hope S Rugo
World Neurosurgery
|
October 17, 2025
Prophylactic Intraventricular Vancomycin: A Potential Paradigm Shift in Ommaya Reservoir-Associated Infection Prevention
Lucas Pari Mitre, Leonardo de Macedo Filho, Michael Glantz
Journal of Neuro-Oncology
|
November 1, 2015
Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey
Tobias Walbert, Michael Glantz, Lonni Schultz, et al.
Seminars in Oncology
|
August 8, 2009
Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more
Ulrich Herrlinger, Michael Glantz, Uwe Schlegel, et al.
The Journal of the American Osteopathic Association
|
January 24, 2007
Adverse drug reaction to methotrexate: pharmacogenetic origin
Peter R Przekop, Henry Tulgan, Allison A Przekop, et al.
Seminars in Oncology
|
August 8, 2009
Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay
Michael Glantz, Santosh Kesari, Lawrence Recht, et al.
Seminars in Oncology
|
August 8, 2009
Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment
Marc C Chamberlain, Michael Glantz, Morris D Groves, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 73) with videos related to
Sort By:
Page
of 8
Neurology
|
February 25, 2011
Is brain the new bone marrow? Stem cells, cancer, and cognition: a working hypothesis
Nimish A Mohile, Christina M Zoccoli, Michael Glantz
Neurology
|
August 12, 2021
VEGF and Immune Checkpoint Inhibition for Prevention of Brain Metastases: Systematic Review and Meta-analysis
Alireza Mansouri, Varun Padmanaban, Dawit Aregawi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2005
Regarding "abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial"
Marc C Chamberlain, Lawrence D Recht, Michael Glantz
Nature Clinical Practice. Oncology
|
October 22, 2008
New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer
Michelle E Melisko, Michael Glantz, Hope S Rugo
World Neurosurgery
|
October 17, 2025
Prophylactic Intraventricular Vancomycin: A Potential Paradigm Shift in Ommaya Reservoir-Associated Infection Prevention
Lucas Pari Mitre, Leonardo de Macedo Filho, Michael Glantz
Journal of Neuro-Oncology
|
November 1, 2015
Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey
Tobias Walbert, Michael Glantz, Lonni Schultz, et al.
Seminars in Oncology
|
August 8, 2009
Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more
Ulrich Herrlinger, Michael Glantz, Uwe Schlegel, et al.
The Journal of the American Osteopathic Association
|
January 24, 2007
Adverse drug reaction to methotrexate: pharmacogenetic origin
Peter R Przekop, Henry Tulgan, Allison A Przekop, et al.
Seminars in Oncology
|
August 8, 2009
Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay
Michael Glantz, Santosh Kesari, Lawrence Recht, et al.
Seminars in Oncology
|
August 8, 2009
Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment
Marc C Chamberlain, Michael Glantz, Morris D Groves, et al.
Page
of 8